This Screenliner short shows how the U.S. Food and Drug Administration (FDA) looks at drug claims that may be fraudulent. In this case, a product called Elixirex is advertised as a cure-all for almost any ailment, including arthritis, rheumatism, and diabetes. After a diabetes patient dies following the use of Elixirex, FDA inspectors start their investigation.
No media sources available
This Screenliner short shows how the U.S. Food and Drug Administration (FDA) looks at drug claims that may be fraudulent. In this case, a product called Elixirex is advertised as a cure-all for almost any ailment, including arthritis, rheumatism, and diabetes. After a diabetes patient dies following the use of Elixirex, FDA inspectors start their investigation.